The Discounted Cash Flow (DCF) valuation of Cellectis SA (ALCLS.PA) is (28.58) EUR. With the latest stock price at 1.86 EUR, the upside of Cellectis SA based on DCF is -1636.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 8.5% | 6.8% |
| Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
| Fair Price | (321.53) - (15.21) | (28.58) |
| Upside | -17386.5% - -918.0% | -1636.4% |